Business Context and Reporting Period
This Form 8-K Current Report was filed by Acadia Healthcare Company, Inc. on June 2, 2023, regarding events occurring on June 1, 2023. The filing discloses significant changes to the company's executive leadership team, specifically the appointment of a new Chief Financial Officer (CFO) and the departure of the incumbent CFO and Executive Vice President of Finance.
Key Financial Metrics
This filing does not contain operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
Executive Leadership Changes
- Appointment: Heather Dixon was appointed as Chief Financial Officer, effective July 10, 2023. She joins from Everside Health, where she served as CFO since June 2021.
- Departure: David Duckworth will resign as Chief Financial Officer, effective July 10, 2023. He will provide advisory support through July 31, 2023.
- Retirement: Larry Harrod will resign as Executive Vice President of Finance, effective June 30, 2023.
Compensation and Employment Terms
Ms. Dixon's employment agreement includes the following compensation components:
- Base Salary: $690,000 annualized.
- Annual Cash Bonus: Target of 85% of Base Salary, with a maximum potential of 170%.
- One-Time Cash Award: $300,000, payable by March 31, 2024, contingent on continued employment.
- Restricted Stock Units (RSUs): One-time grant with a fair value of $2,500,000, vesting ratably over four years.
- Performance Stock Units (PSUs): One-time grant with a target fair value of $3,500,000, vesting over a three-year performance period (Jan 1, 2023 – Dec 31, 2025).
- Severance: Upon a "Qualifying Termination," Ms. Dixon is eligible for 12 months of Base Salary, full vesting of time-based equity, and prorated bonus payments.
Risks and Contingencies
The filing notes that the description of the Employment Agreement is qualified by the full terms of the agreement attached as Exhibit 10.1. No specific financial risks or contingencies regarding the company's operations are disclosed in this report.
Investor Verification Checklist
- Verify the effective dates of the leadership transition (July 10, 2023 for CFO; June 30, 2023 for EVP of Finance).
- Review the full Employment Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason" regarding severance eligibility.
- Confirm the vesting schedules and performance metrics for the $6,000,000 total equity grant (RSUs and PSUs).
- Monitor the transition period through July 31, 2023, where the outgoing CFO provides advisory support.